Goodwin

Michael Shuster

Deals
2
Latest
Feb 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 2 deals

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Michael Shuster was named on, most recent first
Feb 2026 Orna Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Orna Therapeutics (target)Announced2,400.0Biotech+1Eli Lilly and Company acquisition of Orna Therapeutics
Jan 2026 Aktis Oncology ––IPOLegal adviser to the issuerListed317.7Biotech+2Aktis Oncology IPO

Deals where Michael Shuster is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.